Works matching IS 02780232 AND DT 2009 AND VI 27 AND IP 1

Results: 9

Autologous stem cell transplantation for elderly patients with acute myeloid leukaemia conditioned with continuous infusion idarubicin and busulphan.

Published in:

Hematological Oncology, 2009, v. 27, n. 1, p. 40, doi. 10.1002/hon.893

By:

Ferrara, Felicetto;
Palmieri, Salvatore;
Pedata, Mariangela;
Viola, Assunta;
Izzo, Tiziana;
Criscuolo, Clelia;
Mele, Giuseppina

Publication type:

Article

Intravascular large B-cell lymphoma with FDG accumulation in the lung lacking CT/(67)gallium scintigraphy abnormality.

Published in:

2009

By:

Kitanaka A;
Kubota Y;
Imataki O;
Ohnishi H;
Fukumoto T;
Kurokohchi K;
Tanaka T;
Kitanaka, Akira;
Kubota, Yoshitsugu;
Imataki, Osamu;
Ohnishi, Hiroaki;
Fukumoto, Tetsuya;
Kurokohchi, Kazutaka;
Tanaka, Terukazu

Publication type:

journal article

Intravascular large B-cell lymphoma with FDG accumulation in the lung lacking CT/<sup>67</sup>gallium scintigraphy abnormality.

Published in:

Hematological Oncology, 2009, v. 27, n. 1, p. 46, doi. 10.1002/hon.876

By:

Kitanaka, Akira;
Kubota, Yoshitsugu;
Imataki, Osamu;
Ohnishi, Hiroaki;
Fukumoto, Tetsuya;
Kurokohchi, Kazutaka;
Tanaka, Terukazu

Publication type:

Article

High ratio of Duffy (a+b+) phenotype in patients with multiple myeloma compared to healthy controls.

Published in:

Hematological Oncology, 2009, v. 27, n. 1, p. 50, doi. 10.1002/hon.887

By:

Guler, Nil;
Turgut, Mehmet;
Ozatli, Duzgun;
Turgut, Yasemin;
Gokce, Ayse Kevser;
Koc, Salih;
Albayrak, Davut

Publication type:

Article

A phase II clinical trial does not show that high dose simvastatin has beneficial effect on markers of bone turnover in multiple myeloma.

Published in:

Hematological Oncology, 2009, v. 27, n. 1, p. 17, doi. 10.1002/hon.869

By:

Sondergaard, TE;
Pedersen, PT;
Andersen, TL;
Søe, K;
Lund, T;
Østergaard, B;
Garnero, P;
Delaisse, J-M;
Plesner, T

Publication type:

Article

Phase II study of arsenic trioxide and ascorbic acid for relapsed or refractory lymphoid malignancies: a Wisconsin Oncology Network study.

Published in:

Hematological Oncology, 2009, v. 27, n. 1, p. 11, doi. 10.1002/hon.870

By:

Chang, JE;
Voorhees, PM;
Kolesar, JM;
Ahuja, HG;
Sanchez, FA;
Rodriguez, GA;
Kim, K;
Werndli, J;
Bailey, HH;
Kahl, BS

Publication type:

Article

Molecular targeting of the PKC- β inhibitor enzastaurin (LY317615) in multiple myeloma involves a coordinated downregulation of MYC and IRF4 expression.

Published in:

Hematological Oncology, 2009, v. 27, n. 1, p. 23, doi. 10.1002/hon.875

By:

Verdelli, Donata;
Nobili, Lucia;
Todoerti, Katia;
Intini, Daniela;
Cosenza, Maria;
Civallero, Monica;
Bertacchini, Jessika;
Deliliers, Giorgio Lambertenghi;
Sacchi, Stefano;
Lombardi, Luigia;
Neri, Antonino

Publication type:

Article

Prognostic impact of tumour-infiltrating Th2 and regulatory T cells in classical Hodgkin lymphoma.

Published in:

Hematological Oncology, 2009, v. 27, n. 1, p. 31, doi. 10.1002/hon.878

By:

Schreck, Sabine;
Friebel, Daniela;
Buettner, Maike;
Distel, Luitpold;
Grabenbauer, Gerhard;
Young, Lawrence S.;
Niedobitek, Gerald

Publication type:

Article

Richter syndrome: molecular insights and clinical perspectives.

Published in:

Hematological Oncology, 2009, v. 27, n. 1, p. 1, doi. 10.1002/hon.880

By:

Rossi, Davide;
Gaidano, Gianluca

Publication type:

Article